Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Antibody

HEALTH-CORONAVIRUS/USA
RTXHL8SM
September 23, 2021
Registered nurses Johnna Hommell and Jessica Krumwiede attempt to find a vein to administer the Regeneron...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurses Johnna Hommell and Jessica Krumwiede attempt to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8SK
September 23, 2021
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8SL
September 23, 2021
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has her blood pressure taken before attempting to receive the Regeneron monoclonal antibody treatment at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8M9
September 23, 2021
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin,...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton TPX IMAGES OF THE DAY
HEALTH-CORONAVIRUS/USA
RTXHL8GZ
September 23, 2021
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8H1
September 23, 2021
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8H0
September 23, 2021
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurse Jessica Krumwiede attempts to find vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8DK
September 23, 2021
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8DH
September 23, 2021
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has her blood pressure taken before attempting to receive the Regeneron monoclonal antibody treatment from registered nurse Jessica Krumwiede at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8DI
September 23, 2021
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), looks...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), looks up as registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL8DJ
September 23, 2021
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), waits...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), waits for the Regeneron monoclonal antibody treatment at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL89X
September 23, 2021
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin,...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
A registered nurse attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL6KF
September 23, 2021
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL6KE
September 23, 2021
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), has her blood pressure taken before attempting to receive the Regeneron monoclonal antibody treatment from registered nurse Jessica Krumwiede at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL6K9
September 23, 2021
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL6KB
September 23, 2021
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
Registered nurse Jessica Krumwiede attempts to find a vein to administer the Regeneron monoclonal antibody to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/USA
RTXHL6KA
September 23, 2021
The Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts...
Sarasota, UNITED STATES
Regeneron monoclonal antibody treatment at Sarasota Memorial Urgent Care Center in Sarasota, Florida
The Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota, Florida, U.S., September 23, 2021. REUTERS/Shannon Stapleton
HEALTH-CORONAVIRUS/STUDY-TESTS
RTXGZCE9
September 10, 2021
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT...
Chatham, UNITED STATES
An IMPACT study specimen collection kit is seen in Chatham, New Jersey
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid
HEALTH-CORONAVIRUS/STUDY-TESTS
RTXGZCDY
September 10, 2021
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT...
Chatham, UNITED STATES
An IMPACT study specimen collection kit is seen in Chatham, New Jersey
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid
HEALTH-CORONAVIRUS/STUDY-TESTS
RTXGZCDW
September 10, 2021
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT...
Chatham, UNITED STATES
An IMPACT study specimen collection kit is seen in Chatham, New Jersey
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D5O
August 23, 2021
Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) shows an enlarged 3D model...
Ghent, Belgium
Dr. Xavier Saelens shows an enlarged 3D model of a spike protein connected to an antibody in Ghent
Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) shows an enlarged 3D model of a spike protein (blue) connected to an antibody (red), amid the coronavirus disease (COVID-19) pandemic, in Ghent, Belgium August 23, 2021. REUTERS/ Bart Biesemans
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D32
August 23, 2021
An enlarged 3D model of a spike protein (blue) connected to an antibody (red) sits on a table in VIB-UGent...
Ghent, Belgium
An enlarged 3D model of a spike protein connected to an antibody sits on a table in VIB-UGent Center...
An enlarged 3D model of a spike protein (blue) connected to an antibody (red) sits on a table in VIB-UGent Center, amid the coronavirus disease (COVID-19) pandemic, in Ghent, Belgium August 23, 2021. REUTERS/Bart Biesemans
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2K
August 23, 2021
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens (VIB-UGent Center for Medical...
Ghent, Belgium
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens, Dr. Xavier Saelens and Dr....
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert Schepens (VIB-UGent Center for Medical Biotechnology research), Dr. Xavier Saelens (VIB-UGent Center for Medical Biotechnology group leader) and Dr. Nico Callewaert (director of the VIB-UGent Center for Medical Biotechnology) show an enlarged 3D model of a spike protein (blue) connected to an antibody (red) in Ghent, Belgium August 23, 2021. REUTERS/ Bart Biesemans
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2O
August 23, 2021
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease...
Genk, Belgium
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/Johanna Geron
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2M
August 23, 2021
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease...
Genk, Belgium
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron TPX IMAGES OF THE DAY
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2S
August 23, 2021
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease...
Genk, Belgium
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2R
August 23, 2021
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease...
Genk, Belgium
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2Y
August 23, 2021
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease...
Genk, Belgium
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron
HEALTH-CORONAVIRUS/MEDICINE-LLAMA
RTXG3D2U
August 23, 2021
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease...
Genk, Belgium
A llama called Winter, whose antibodies were used in the hunt for a treatment for COVID-19
A llama called Winter, whose antibodies were used in the hunt for a treatment for the coronavirus disease (COVID-19), stands in a meadow in Genk, Belgium August 23, 2021. REUTERS/ Johanna Geron
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPINB
April 22, 2021
A health worker holds up a vial of Imdevimab, an antibody cocktail designed to produce resistance to...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
A health worker holds up a vial of Imdevimab, an antibody cocktail designed to produce resistance to the coronavirus disease (COVID-19), at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPINA
April 22, 2021
A health worker checks the parameters of Andrea Sconocchia, a coronavirus disease (COVID-19) patient,...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
A health worker checks the parameters of Andrea Sconocchia, a coronavirus disease (COVID-19) patient, before giving him an intravenous administration of a monoclonal antibody treatment, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPIIA
April 22, 2021
A health worker looks on as coronavirus disease (COVID-19) patients undergo intravenous monoclonal antibody...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
A health worker looks on as coronavirus disease (COVID-19) patients undergo intravenous monoclonal antibody treatment, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPIEP
April 22, 2021
A medical health worker administers an intravenous dose of monoclonal antibody treatment to Antonio Rapuano,...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for Covid patients
A medical health worker administers an intravenous dose of monoclonal antibody treatment to Antonio Rapuano, a coronavirus disease (COVID-19) patient, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPICI
April 22, 2021
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for Covid patients
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being administered intravenously to a coronavirus disease (COVID-19) patient, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPIAY
April 22, 2021
Antonio Rapuano, a coronavirus disease (COVID-19) patient, looks on as a health worker preps him to receive...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for (COVID-19) patients
Antonio Rapuano, a coronavirus disease (COVID-19) patient, looks on as a health worker preps him to receive an intravenous dose of monoclonal antibody treatment, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPI6G
April 22, 2021
A health worker smiles at Antonio Rapuano, a coronavirus disease (COVID-19) patient, as he is administered...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
A health worker smiles at Antonio Rapuano, a coronavirus disease (COVID-19) patient, as he is administered the monoclonal antibody treatment intravenously, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHWD
April 22, 2021
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
A health worker looks at an infusion bottle containing a monoclonal antibody treatment as it is being administered intravenously to a coronavirus disease (COVID-19) patient, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHWC
April 22, 2021
A health worker looks at Andrea Sconocchia, a coronavirus disease (COVID-19) patient, as he is administered...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for Covid patients
A health worker looks at Andrea Sconocchia, a coronavirus disease (COVID-19) patient, as he is administered the monoclonal antibody treatment intravenously, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHI3
April 22, 2021
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal antibody treatment before giving him an intravenous administration of the drug, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHHW
April 22, 2021
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as he is administered the monoclonal...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
Andrea Sconocchia, coronavirus disease (COVID-19) patient, looks on as he is administered the monoclonal antibody treatment intravenously, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/ITALY-ANTIBODIES
RTXBPHBW
April 22, 2021
Antonio Rapuano, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal...
Albano, Italy
Albano hospital begins monoclonal antibody treatment for COVID-19 patients
Antonio Rapuano, coronavirus disease (COVID-19) patient, looks on as a health worker prepares a monoclonal antibody treatment before giving him an intravenous administration of the drug, at San Giuseppe Hospital, in Albano, Italy, April 22, 2021. REUTERS/Yara Nardi
HEALTH-CORONAVIRUS/MONOCLONAL ANTIBODY
RTXBMCSQ
April 19, 2021
Health professionals and local politicians pose for a Alejandra Perez to take a picture as they gather...
Chula Vista, UNITED STATES
Monoclonal antibody treatment for COVID-19 positive individuals opens in former fire station in California...
Health professionals and local politicians pose for a Alejandra Perez to take a picture as they gather to open a free monoclonal antibody treatment center for COVID-19 positive individuals at a former fire station in Chula Vista, California, U.S., April 19, 2021. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/MONOCLONAL ANTIBODY
RTXBMCSO
April 19, 2021
A healthcare worker waits outside outside a former fire station that opened today as a monoclonal antibody...
Chula Vista, UNITED STATES
Monoclonal antibody treatment for COVID-19 positive individuals opens in former fire station in California...
A healthcare worker waits outside outside a former fire station that opened today as a monoclonal antibody treatment center for COVID-19 positive individuals in Chula Vista, California, U.S., April 19, 2021. REUTERS/Mike Blake
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66Y
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, says good-bye upon leaving...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, says good-bye upon leaving the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66X
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, bids farewell to fellow...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, bids farewell to fellow resident Antonia Sanchez at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera TPX IMAGES OF THE DAY
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66O
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66P
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66Q
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, sits at her designated...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, sits at her designated spot for breakfast at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I66R
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I65L
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, waits for the arrival of...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, waits for the arrival of her son at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I65K
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, gets hugged by her son...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer?s disease, gets hugged by her son Enrique Suarez at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/SPAIN-CHRISTMAS
RTX8I65J
December 24, 2020
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease,...
NAVALCARNERO, Spain
COVID-19 survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, gets hugged by her son...
The coronavirus disease (COVID-19) survivor Santiaga Cerrato, 85, who suffers from Alzheimer’s disease, gets hugged by her son Enrique Suarez at the nursing home Centro Casaverde in Navalcarnero, outside Madrid, Spain, December 23, 2020. Under the Madrid region's coronavirus restrictions elderly residents like Santiaga are allowed to visit family over the holidays if they have coronavirus antibodies that can guarantee their immunity to the disease. Cerrato will have to undergo diagnostic and antibodies tests prior to going back to the nursing home to determine whether she must observe a quarantine period upon her return. Picture taken December 23, 2020. REUTERS/Susana Vera
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N35
November 15, 2020
Hungarian biologists Alexandra Torok and Noemi Lukacs check the purity of an antibody, a genetic sensor...
SZIRAK, Hungary
Hungarian biologists Torok and Lukacs check the purity of an antibody, in Szirak
Hungarian biologists Alexandra Torok and Noemi Lukacs check the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N34
November 15, 2020
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured...
SZIRAK, Hungary
Hungarian biologist Torok checks the purity of an antibody, in Szirak
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N33
November 15, 2020
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured...
SZIRAK, Hungary
Hungarian biologist Torok checks the purity of an antibody, in Szirak
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N32
November 15, 2020
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured...
SZIRAK, Hungary
Hungarian biologist Torok checks the purity of an antibody, in Szirak
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N2X
November 15, 2020
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured...
SZIRAK, Hungary
Hungarian biologist Torok checks the purity of an antibody, in Szirak
Hungarian biologist Alexandra Torok checks the purity of an antibody, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N2V
November 15, 2020
Hungarian biologist, Noemi Lukacs shows test tubes with antibodies, a genetic sensor of sorts, manufactured...
SZIRAK, Hungary
Hungarian biologist, Noemi Lukacs shows test tubes with antibodies, in Szirak
Hungarian biologist, Noemi Lukacs shows test tubes with antibodies, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/VACCINE-HUNGARY
RTX89N2U
November 15, 2020
Hungarian biologist, Noemi Lukacs shows a test tube with antibodies, a genetic sensor of sorts, manufactured...
SZIRAK, Hungary
Hungarian biologist, Noemi Lukacs shows a test tube with antibodies, in Szirak
Hungarian biologist, Noemi Lukacs shows a test tube with antibodies, a genetic sensor of sorts, manufactured by a small family company and sold to the largest pharmaceutical companies in the race for a coronavirus vaccine, in Szirak, Hungary, November 13, 2020. Picture taken November 13, 2020. REUTERS/Bernadett Szabo
HEALTH-CORONAVIRUS/LONZA-VACCINE
RTX7YRZ6
September 29, 2020
Staff set up an antibody production line at the Ibex building of Lonza, where the Moderna mRNA coronavirus...
VISP, Switzerland
Staff set up an antibody production line at the Ibex building of Lonza in Visp
Staff set up an antibody production line at the Ibex building of Lonza, where the Moderna mRNA coronavirus disease (COVID-19) vaccine will be produced, in Visp, Switzerland, September 29, 2020. REUTERS/Denis Balibouse
Sort by
Display
Items per page
Page
of 7